Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
agree
agree.
thanks, Rutt, very interesting points you make.
Two more new national polls show that a majority of Americans are in favor of legalizing cannabis.
A Fox News survey, which involved phone interviews with 1,000 adults from December 8-11, showed that 63 percent of respondents support legalizing “the recreational use of marijuana on a national level,” while 34 percent oppose the policy.
A Marist poll, conducted in collaboration with NPR and PBS, surveyed 1,744 Americans from December 9-11. The results similarly showed 62 percent of respondents saying it is a “good idea” to legalize cannabis, with 33 stating it would be a “bad idea.”
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Is hope being wasted on President Trump legalising cannabis in the USA...?
"Voters who supported President Trump in the 2016 election expressed greater opposition to the policy than Republicans and Republican-leaning independents as a whole. Forty percent of Trump supporters said they back legalization, compared to 55 percent who said it was a bad idea."
Do Americans need a young, or a socialist, Democratic candidate to become president before cannabis is federally legalised in the US…?
"Given this widespread support, particularly among Democratic voters, it’s clear why the issue has become a major talking point for the majority of the party’s 2020 presidential candidates, almost all of whom back legalization, with notable exceptions of former Vice President Joe Biden and billionaire Michael Bloomberg."
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Is hope being wasted on President Trump legalising cannabis in the USA...?
"Voters who supported President Trump in the 2016 election expressed greater opposition to the policy than Republicans and Republican-leaning independents as a whole. Forty percent of Trump supporters said they back legalization, compared to 55 percent who said it was a bad idea."
Do Americans need a young, or a socialist, Democratic candidate to become president before cannabis is federally legalised in the US…?
"Given this widespread support, particularly among Democratic voters, it’s clear why the issue has become a major talking point for the majority of the party’s 2020 presidential candidates, almost all of whom back legalization, with notable exceptions of former Vice President Joe Biden and billionaire Michael Bloomberg."
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Do Americans need a young, or a socialist, Democratic candidate to become president before cannabis is legalised in the US…?
"Given this widespread support, particularly among Democratic voters, it’s clear why the issue has become a major talking point for the majority of the party’s 2020 presidential candidates, almost all of whom back legalization, with notable exceptions of former Vice President Joe Biden and billionaire Michael Bloomberg."
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Are we wasting our hopes on President Trump legalising cannabis in the USA...?
"Voters who supported President Trump in the 2016 election expressed greater opposition to the policy than Republicans and Republican-leaning independents as a whole. Forty percent of Trump supporters said they back legalization, compared to 55 percent who said it was a bad idea."
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Majority Of Americans Support Marijuana Legalization...
Two more new national polls show that a majority of Americans are in favor of legalizing marijuana.
A Fox News survey, which involved phone interviews with 1,000 adults from December 8-11, showed that 63 percent of respondents support legalizing “the recreational use of marijuana on a national level,” while 34 percent oppose the policy.
A Marist poll, conducted in collaboration with NPR and PBS, surveyed 1,744 Americans from December 9-11. The results similarly showed 62 percent of respondents saying it is a “good idea” to legalize cannabis, with 33 stating it would be a “bad idea.”
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Majority Of Americans Support Marijuana Legalization...
Two more new national polls show that a majority of Americans are in favor of legalizing marijuana.
A Fox News survey, which involved phone interviews with 1,000 adults from December 8-11, showed that 63 percent of respondents support legalizing “the recreational use of marijuana on a national level,” while 34 percent oppose the policy.
A Marist poll, conducted in collaboration with NPR and PBS, surveyed 1,744 Americans from December 9-11. The results similarly showed 62 percent of respondents saying it is a “good idea” to legalize cannabis, with 33 stating it would be a “bad idea.”
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
Two more new national polls show that a majority of Americans are in favor of legalizing marijuana.
A Fox News survey, which involved phone interviews with 1,000 adults from December 8-11, showed that 63 percent of respondents support legalizing “the recreational use of marijuana on a national level,” while 34 percent oppose the policy.
A Marist poll, conducted in collaboration with NPR and PBS, surveyed 1,744 Americans from December 9-11. The results similarly showed 62 percent of respondents saying it is a “good idea” to legalize cannabis, with 33 stating it would be a “bad idea.”
https://www.marijuanamoment.net/majority-of-americans-support-marijuana-legalization-two-more-new-polls-show/
The world’s biggest brewer will kick off its push into cannabis-infused beverages with a lineup of flavored teas -- Lavender Chamomile, Vanilla Rooibos and Peach Ginger Green.
The “Everie” teas will contain 98% pure cannabidiol, the non-psychotropic ingredient in cannabis, with only a trace -- 0.05 milligrams -- of THC, the component that gets you high. They will be sold through Fluent Beverages, a joint venture between Anheuser-Busch InBev NV’s Labatt Breweries of Canada and pot company Tilray Inc.’s High Park Co.
https://www.bloomberg.com/news/articles/2019-12-11/move-over-bud-ab-inbev-will-soon-sell-cbd-infused-tea-in-canada
this is still such a young universe.
lol
and spot on, Twister.
LUSAKA (Reuters) - Zambia has legalized the production and export of cannabis for economic and medicinal purposes, the government’s chief spokeswoman said on Monday, becoming the latest country to shift its position on the drug to give its finances a boost.
The approval for the export of cannabis was granted at a special cabinet meeting on Dec. 4, spokeswoman Dora Siliya said in a statement. It was not clear from the statement if the use of cannabis for medicinal purposes in Zambia had been legalized.
The southern African country joins a host of nations that have legalized, or are considering legalizing cannabis to some degree, as attitudes towards the drug slowly change and investments in its medical benefits grow.
https://www.reuters.com/article/us-zambia-cannabis/zambia-approves-cannabis-exports-to-boost-economy-idUSKBN1YK1XU
LUSAKA (Reuters) - Zambia has legalized the production and export of cannabis for economic and medicinal purposes, the government’s chief spokeswoman said on Monday, becoming the latest country to shift its position on the drug to give its finances a boost.
The approval for the export of cannabis was granted at a special cabinet meeting on Dec. 4, spokeswoman Dora Siliya said in a statement. It was not clear from the statement if the use of cannabis for medicinal purposes in Zambia had been legalized.
The southern African country joins a host of nations that have legalized, or are considering legalizing cannabis to some degree, as attitudes towards the drug slowly change and investments in its medical benefits grow.
https://www.reuters.com/article/us-zambia-cannabis/zambia-approves-cannabis-exports-to-boost-economy-idUSKBN1YK1XU
Using e-cigarettes increases the risk of chronic lung diseases including asthma, bronchitis and emphysema, a study has found.
The research, which tracked more than 32,000 people, found that vaping was less dangerous than traditional cigarettes, which were found to more than double the risk of lung disease.
Few of the subjects who used e-cigarettes completely gave up ordinary cigarettes, however, during the three-year study. Public Health England says that vaping helps smokers to quit.
A study by University College London had suggested that e-cigarettes could be helping 70,000 smokers to quit in England each year. Cancer Research UK has strongly discouraged non-smokers from taking up vaping, saying that the long-term risks were unknown.
https://www.thetimes.co.uk/edition/news/vaping-raises-risk-of-chronic-lung-disease-zt556jdp9
Using e-cigarettes increases the risk of chronic lung diseases including asthma, bronchitis and emphysema, a study has found.
The research, which tracked more than 32,000 people, found that vaping was less dangerous than traditional cigarettes, which were found to more than double the risk of lung disease.
Few of the subjects who used e-cigarettes completely gave up ordinary cigarettes, however, during the three-year study. Public Health England says that vaping helps smokers to quit.
A study by University College London had suggested that e-cigarettes could be helping 70,000 smokers to quit in England each year. Cancer Research UK has strongly discouraged non-smokers from taking up vaping, saying that the long-term risks were unknown.
https://www.thetimes.co.uk/edition/news/vaping-raises-risk-of-chronic-lung-disease-zt556jdp9
Peruvian authorities to allow businesses to begin applications for medical cannabis licenses, and further outline a clear licensing process
Khiron has secured Good Storage Practices (GSP) certification, a crucial prerequisite for import and commercialization license applications in Peru
Company has submitted its security protocols for regulatory review as a further step to securing key licenses
With a population of 32 million, Peru's medical cannabis market is estimated to be worth $99 million (Prohibition Partners)
Strong cash balance firmly positions Company to capitalize on emerging market opportunities in Peru
TORONTO, Dec. 16, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America, today welcomes the release of regulatory guidelines governing the medical cannabis program in Peru, and concurrently, announces its receipt of Good Storage Practices (GSP) certification in the country. Issued by Peru's Ministry of Health earlier this week, the new regulatory guidelines establish clear steps towards securing licenses for the import and commercialization of medical cannabis, for which GSP certification is a crucial prerequisite.
https://investors.khiron.ca/investor-information/news-events/press-releases/detail/136/khiron-welcomes-regulatory-guidelines-in-peru-announces
Nice find, thanks Dhbuzz.
December 16 ... is it today that Canna 2.0 kicks in...?
Are the new products (beverages, extracts, edibles, topicals etc etc) legally allowed to be sold from today...?
December 16 ... is it today that Canna 2.0 kicks in...?
Are the new products (beverages, extracts, edibles, topicals etc etc) legally allowed to be sold from today...?
Thanks, Funman. I do really like the way you give the link and copy and paste the article. Very professional that helps us investors with DD.
Marijuana Legalization Could Be Coming To These States In 2020
https://www.forbes.com/sites/kriskrane/2019/12/11/marijuana-legalization-could-be-coming-to-these-states-in-2020/#1560736699b5
Why Investors Should be Bullish About GW Pharmaceuticals (GWPH)
https://stocknews.com/news/gwph-why-investors-should-be-bullish-gw-pharmaceuticals-gwph/
Is Now the Time to Buy Shares of Aurora Cannabis (ACB)?
https://stocknews.com/news/acb-is-now-the-time-to-buy-shares-of-aurora-cannabis/
6 Reasons Why Investors Should Be Bullish About Aphria (APHA)
https://stocknews.com/news/apha-6-reasons-investors-should-be-bullish-about-aphria-apha/
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
SUPREME (FIRE)
The 8 analysts offering 12 month price targets for Supreme Cannabis Company Inc have a median target of 1.25, with a high estimate of 1.75 and a low estimate of 0.70. The median estimate represents a 89.39% increase from the last price of 0.66.
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
ORGANIGRAM
The 14 analysts offering 12 month price targets for OrganiGram Holdings Inc have a median target of 7.00, with a high estimate of 13.30 and a low estimate of 4.00. The median estimate represents a 108.33% increase from the last price of 3.36.
Financial Times share price forecasts (13-Dec-2019)
GWPH
The 15 analysts offering 12 month price targets for GW Pharmaceuticals PLC- ADR have a median target of 200.00, with a high estimate of 260.00 and a low estimate of 160.00. The median estimate represents a 89.21% increase from the last price of 105.70. ($US)
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
CURALEAF
The 4 analysts offering 12 month price targets for Curaleaf Holdings Inc have a median target of 10.75, with a high estimate of 13.00 and a low estimate of 7.25. The median estimate represents a 36.42% increase from the last price of 7.88.
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
APHRIA
The 13 analysts offering 12 month price targets for Aphria Inc have a median target of 10.40, with a high estimate of 26.00 and a low estimate of 6.50. The median estimate represents a 49.86% increase from the last price of 6.94.
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
KHRN
The 3 analysts offering 12 month price targets for Khiron Life Sciences Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 3.25. The median estimate represents a 321.05% increase from the last price of 0.95.
Financial Times share price forecasts (13-Dec-2019)
(In $CAD)
AURORA
The 15 analysts offering 12 month price targets for Aurora Cannabis Inc have a median target of 6.00, with a high estimate of 10.59 and a low estimate of 2.80. The median estimate represents a 74.42% increase from the last price of 3.44.
well done, Kush.
A bright new year on the way to Canopy longs.
nice one, Kush.
You are our ace reporter.
well let's hope it does that tomorrow.
great day... of many great days ahead for Aphria.
wow, Kush, this is big news...
happy days...